VIVO
Assenagon Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-280,426
| Closed | -$8.84M | – | 1445 |
|
|
2022
Q3 | $8.84M | Buy |
280,426
+100,256
| +56% | +$3.16M | 0.03% | 349 |
|
|
2022
Q2 | $5.48M | Buy |
180,170
+52,963
| +42% | +$1.61M | 0.02% | 490 |
|
|
2022
Q1 | $3.3M | Sell |
127,207
-92,449
| -42% | -$2.4M | 0.01% | 634 |
|
|
2021
Q4 | $4.48M | Buy |
+219,656
| New | +$4.48M | 0.01% | 522 |
|
|
2020
Q2 | – | Sell |
-606,621
| Closed | -$5.1M | – | 1236 |
|
|
2020
Q1 | $5.1M | Buy |
606,621
+92,964
| +18% | +$781K | 0.04% | 198 |
|
|
2019
Q4 | $5.02M | Buy |
513,657
+172,857
| +51% | +$1.69M | 0.03% | 205 |
|
|
2019
Q3 | $3.23M | Sell |
340,800
-371,789
| -52% | -$3.53M | 0.02% | 274 |
|
|
2019
Q2 | $8.47M | Buy |
+712,589
| New | +$8.47M | 0.06% | 151 |
|
|
2019
Q1 | – | Sell |
-64,472
| Closed | -$1.12M | – | 1121 |
|
|
2018
Q4 | $1.12M | Sell |
64,472
-224,198
| -78% | -$3.89M | 0.01% | 577 |
|
|
2018
Q3 | $4.3M | Buy |
+288,670
| New | +$4.3M | 0.04% | 294 |
|
|
2018
Q1 | – | Sell |
-268,889
| Closed | -$3.76M | – | 748 |
|
|
2017
Q4 | $3.76M | Buy |
+268,889
| New | +$3.76M | 0.04% | 255 |
|